Cargando…
Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
OBJECTIVES: Emerging evidence demonstrates that aPS-PT associate with thrombotic events. Genetic predisposition, including HLA-DRB1 alleles, is known to contribute to the occurrence of conventional aPL [anti-β(2)glycoprotein-I (anti-β(2)GPI) and aCL]. We investigated associations between aPS-PT and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891424/ https://www.ncbi.nlm.nih.gov/pubmed/35642868 http://dx.doi.org/10.1093/rheumatology/keac327 |
_version_ | 1784881134000144384 |
---|---|
author | Elbagir, Sahwa Diaz-Gallo, Lina-Marcela Grosso, Giorgia Zickert, Agneta Gunnarsson, Iva Mahler, Michael Svenungsson, Elisabet Rönnelid, Johan |
author_facet | Elbagir, Sahwa Diaz-Gallo, Lina-Marcela Grosso, Giorgia Zickert, Agneta Gunnarsson, Iva Mahler, Michael Svenungsson, Elisabet Rönnelid, Johan |
author_sort | Elbagir, Sahwa |
collection | PubMed |
description | OBJECTIVES: Emerging evidence demonstrates that aPS-PT associate with thrombotic events. Genetic predisposition, including HLA-DRB1 alleles, is known to contribute to the occurrence of conventional aPL [anti-β(2)glycoprotein-I (anti-β(2)GPI) and aCL]. We investigated associations between aPS-PT and HLA-DRB1* alleles and thrombosis in SLE. Conventional aPL were included for comparison. METHODS: We included 341 consecutive SLE patients, with information on general cardiovascular risk factors, including blood lipids, LA and thrombotic events. aPS/PT, anti-β(2)GPI and aCL of IgA/G/M isotypes and LA were quantified. RESULTS: aPS/PT antibodies associated positively with HLA-DRB1*13 [odds ratio (OR) 2.7, P = 0.002], whereas anti-β(2)GPI and aCL antibodies associated primarily with HLA-DRB1*04 (OR 2.5, P = 0.0005). These associations remained after adjustment for age, gender and other HLA-DRB1* alleles. HLA-DRB1*13, but not DRB1*04, remained as an independent risk factor for thrombosis and APS after adjustment for aPL and cardiovascular risk factors. The association between DRB1*13 and thrombosis was mediated by aPS-PT positivity. HLA-DRB1*03, on the other hand, associated negatively with thrombotic events as well as all aPL using both uni- and multivariate analyses. HLA-DRB1*03 had a thrombo-protective effect in aPL-positive patients. Additionally, HLA-DRB1*03 was associated with a favourable lipid profile regarding high-density lipoprotein and triglycerides. CONCLUSIONS: HLA-DRB1*13 confers risk for both aPS-PT and thrombotic events in lupus. The association between HLA-DRB1*13 and thrombosis is largely, but not totally, mediated through aPS-PT. HLA-DRB1*03 was negatively associated with aPL and positively with favourable lipid levels. Thus, HLA-DRB1*03 seems to identify a subgroup of SLE patients with reduced vascular risk. |
format | Online Article Text |
id | pubmed-9891424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98914242023-02-02 Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE Elbagir, Sahwa Diaz-Gallo, Lina-Marcela Grosso, Giorgia Zickert, Agneta Gunnarsson, Iva Mahler, Michael Svenungsson, Elisabet Rönnelid, Johan Rheumatology (Oxford) Basic Science OBJECTIVES: Emerging evidence demonstrates that aPS-PT associate with thrombotic events. Genetic predisposition, including HLA-DRB1 alleles, is known to contribute to the occurrence of conventional aPL [anti-β(2)glycoprotein-I (anti-β(2)GPI) and aCL]. We investigated associations between aPS-PT and HLA-DRB1* alleles and thrombosis in SLE. Conventional aPL were included for comparison. METHODS: We included 341 consecutive SLE patients, with information on general cardiovascular risk factors, including blood lipids, LA and thrombotic events. aPS/PT, anti-β(2)GPI and aCL of IgA/G/M isotypes and LA were quantified. RESULTS: aPS/PT antibodies associated positively with HLA-DRB1*13 [odds ratio (OR) 2.7, P = 0.002], whereas anti-β(2)GPI and aCL antibodies associated primarily with HLA-DRB1*04 (OR 2.5, P = 0.0005). These associations remained after adjustment for age, gender and other HLA-DRB1* alleles. HLA-DRB1*13, but not DRB1*04, remained as an independent risk factor for thrombosis and APS after adjustment for aPL and cardiovascular risk factors. The association between DRB1*13 and thrombosis was mediated by aPS-PT positivity. HLA-DRB1*03, on the other hand, associated negatively with thrombotic events as well as all aPL using both uni- and multivariate analyses. HLA-DRB1*03 had a thrombo-protective effect in aPL-positive patients. Additionally, HLA-DRB1*03 was associated with a favourable lipid profile regarding high-density lipoprotein and triglycerides. CONCLUSIONS: HLA-DRB1*13 confers risk for both aPS-PT and thrombotic events in lupus. The association between HLA-DRB1*13 and thrombosis is largely, but not totally, mediated through aPS-PT. HLA-DRB1*03 was negatively associated with aPL and positively with favourable lipid levels. Thus, HLA-DRB1*03 seems to identify a subgroup of SLE patients with reduced vascular risk. Oxford University Press 2022-06-01 /pmc/articles/PMC9891424/ /pubmed/35642868 http://dx.doi.org/10.1093/rheumatology/keac327 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Basic Science Elbagir, Sahwa Diaz-Gallo, Lina-Marcela Grosso, Giorgia Zickert, Agneta Gunnarsson, Iva Mahler, Michael Svenungsson, Elisabet Rönnelid, Johan Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE |
title | Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE |
title_full | Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE |
title_fullStr | Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE |
title_full_unstemmed | Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE |
title_short | Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE |
title_sort | anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with hla-drb1*13 and negatively with hla-drb1*03 in sle |
topic | Basic Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891424/ https://www.ncbi.nlm.nih.gov/pubmed/35642868 http://dx.doi.org/10.1093/rheumatology/keac327 |
work_keys_str_mv | AT elbagirsahwa antiphosphatidylserineprothrombinantibodiesandthrombosisassociatepositivelywithhladrb113andnegativelywithhladrb103insle AT diazgallolinamarcela antiphosphatidylserineprothrombinantibodiesandthrombosisassociatepositivelywithhladrb113andnegativelywithhladrb103insle AT grossogiorgia antiphosphatidylserineprothrombinantibodiesandthrombosisassociatepositivelywithhladrb113andnegativelywithhladrb103insle AT zickertagneta antiphosphatidylserineprothrombinantibodiesandthrombosisassociatepositivelywithhladrb113andnegativelywithhladrb103insle AT gunnarssoniva antiphosphatidylserineprothrombinantibodiesandthrombosisassociatepositivelywithhladrb113andnegativelywithhladrb103insle AT mahlermichael antiphosphatidylserineprothrombinantibodiesandthrombosisassociatepositivelywithhladrb113andnegativelywithhladrb103insle AT svenungssonelisabet antiphosphatidylserineprothrombinantibodiesandthrombosisassociatepositivelywithhladrb113andnegativelywithhladrb103insle AT ronnelidjohan antiphosphatidylserineprothrombinantibodiesandthrombosisassociatepositivelywithhladrb113andnegativelywithhladrb103insle |